ReviewAntioxidants (Basel, Switzerland)2026

NRF2-Targeted Therapy in Cardiovascular Disease Transitions from Systemic Activation to Precision Redox Medicine.

Yizhao Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.